APA (7th ed.) Citation

Weidenbusch, B., & Witt, O. (2018). Transcriptome based individualized therapy of refractory pediatric sarcomas: Feasibility, tolerability and efficacy. OncoTarget, 9(29), . https://doi.org/10.18632/oncotarget.25087

Chicago Style (17th ed.) Citation

Weidenbusch, Bushra, and Olaf Witt. "Transcriptome Based Individualized Therapy of Refractory Pediatric Sarcomas: Feasibility, Tolerability and Efficacy." OncoTarget 9, no. 29 (2018). https://doi.org/10.18632/oncotarget.25087.

MLA (9th ed.) Citation

Weidenbusch, Bushra, and Olaf Witt. "Transcriptome Based Individualized Therapy of Refractory Pediatric Sarcomas: Feasibility, Tolerability and Efficacy." OncoTarget, vol. 9, no. 29, 2018, https://doi.org/10.18632/oncotarget.25087.